DK1335743T3 - Inhibering eller reversering af hudældning ved hjælp af actinsekvestrerende peptider - Google Patents

Inhibering eller reversering af hudældning ved hjælp af actinsekvestrerende peptider

Info

Publication number
DK1335743T3
DK1335743T3 DK01981902.8T DK01981902T DK1335743T3 DK 1335743 T3 DK1335743 T3 DK 1335743T3 DK 01981902 T DK01981902 T DK 01981902T DK 1335743 T3 DK1335743 T3 DK 1335743T3
Authority
DK
Denmark
Prior art keywords
reversal
inhibition
skin aging
actin sequestering
actin
Prior art date
Application number
DK01981902.8T
Other languages
Danish (da)
English (en)
Inventor
Allan L Goldstein
Original Assignee
Regenerx Biopharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regenerx Biopharmaceuticals filed Critical Regenerx Biopharmaceuticals
Application granted granted Critical
Publication of DK1335743T3 publication Critical patent/DK1335743T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK01981902.8T 2000-11-02 2001-11-02 Inhibering eller reversering af hudældning ved hjælp af actinsekvestrerende peptider DK1335743T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24490100P 2000-11-02 2000-11-02
PCT/US2001/042900 WO2002036143A1 (en) 2000-11-02 2001-11-02 Inhibition or reversal of skin aging by actin-sequestering peptides

Publications (1)

Publication Number Publication Date
DK1335743T3 true DK1335743T3 (da) 2010-04-06

Family

ID=22924553

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01981902.8T DK1335743T3 (da) 2000-11-02 2001-11-02 Inhibering eller reversering af hudældning ved hjælp af actinsekvestrerende peptider

Country Status (10)

Country Link
EP (1) EP1335743B1 (enExample)
JP (2) JP4224297B2 (enExample)
AT (1) ATE452647T1 (enExample)
AU (2) AU1351302A (enExample)
CA (1) CA2426200C (enExample)
DE (1) DE60140892D1 (enExample)
DK (1) DK1335743T3 (enExample)
ES (1) ES2338633T3 (enExample)
PT (1) PT1335743E (enExample)
WO (1) WO2002036143A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2311485A1 (en) 1998-07-30 2011-04-20 The Government of the United States of America, as represented by the Secretary of Health and Human Services Thymosin beta 4 promotes wound repair
US6821524B2 (en) * 2002-06-03 2004-11-23 Jan Marini Skin Research, Inc. Cosmetic skin care compositions
WO2005087805A1 (en) * 2004-03-05 2005-09-22 Regenerx Biopharmaceuticals, Inc. Treating or preventing extracellular matrix build-up
MX2008001084A (es) 2005-07-26 2008-03-11 Regenerx Biopharmaceuticals Composiciones para el tratamiento o prevencion del deterioro, lesion o dano de tejido debido a insuficiencia cardiaca congestiva.
EP2260106A4 (en) * 2008-03-17 2011-04-20 Regenerx Biopharmaceuticals IMPROVED BETATHYMOSINFRAGMENTS
US9808654B2 (en) 2013-02-11 2017-11-07 Jan Marini Skin Research Post procedure skin care gel and methods of use thereof
KR102265430B1 (ko) * 2019-08-20 2021-06-15 주식회사 케어젠 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9806632D0 (en) 1998-03-28 1998-05-27 Stevenson Robert Peptide factor
EP2311485A1 (en) 1998-07-30 2011-04-20 The Government of the United States of America, as represented by the Secretary of Health and Human Services Thymosin beta 4 promotes wound repair

Also Published As

Publication number Publication date
CA2426200A1 (en) 2002-05-10
JP2004527463A (ja) 2004-09-09
JP4224297B2 (ja) 2009-02-12
JP2009046502A (ja) 2009-03-05
AU2002213513B2 (en) 2006-05-25
CA2426200C (en) 2014-08-19
EP1335743A1 (en) 2003-08-20
WO2002036143A1 (en) 2002-05-10
PT1335743E (pt) 2010-03-29
AU1351302A (en) 2002-05-15
DE60140892D1 (de) 2010-02-04
ES2338633T3 (es) 2010-05-11
EP1335743A4 (en) 2004-09-15
EP1335743B1 (en) 2009-12-23
ATE452647T1 (de) 2010-01-15

Similar Documents

Publication Publication Date Title
BRPI0017013B8 (pt) composição de antibiótico azalídeo e método para sua obtenção
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
ITRM920155A0 (it) Composizione farmaceutica contenente 3-2 (dimetilammino) etil-n-metil-1h-indol-5-metansolfonammide, e relativo procedimento di preparazione e trattamento con essa di mammiferi.
DE59608274D1 (de) Cyclosporin-derivate mit anti-hiv-wirkung
AU9315398A (en) Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
DK1335743T3 (da) Inhibering eller reversering af hudældning ved hjælp af actinsekvestrerende peptider
AR015945A1 (es) Composiciones de spray para el cabello autofobicas
NO983530D0 (no) Dihydrobenzofuran og relaterte forbindelser anvendelig som anti-inflammatoriske midler
IT1212508B (it) Analoghi retro - invertiti dei penta - ed esapeptidi c - terminali della sostanza p. utili come vasodilatatori
ES2180948T3 (es) Peptido que proviene de una forma soluble de la acetilcolinesterasa, activo como modulador del canal.
ATE210149T1 (de) Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden
DK0977716T3 (da) Anvendelse af alkoholer som additiver til puds og/eller mørtel
AR009819A1 (es) Inhibidores de la proteasa proteinicos estabilizados y sus variantes
ES2194744T3 (es) Derivados de quinocardina, su procedimiento de preparacion y su aplicacion como antifungicos.
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
YU41796A (sh) Smeše za poboljšanje podnošljivosti delotvornih beta-amino kiselina
DK0952982T3 (da) Hidtil ukendte hepatitis B inhibitorer
DE60006108D1 (de) Lineare Approximation des LOG-MAP Algorithmus für Turbodekodierung
DK1196440T3 (da) Terapeutiske peptider afledt af subsekvenser af BPI
DK1194158T3 (da) Anvendelse af UK 114-proteiner til hæmning af organtransplantatafstödning
DK1079836T3 (da) Anvendelse af danazol til behandling af hypogonadisme hos mænd
DE59709976D1 (de) Schwimmbecken
NO931745L (no) Stabiliserte, sterkt virkende grf-analoger
ES2175991T3 (es) Obra da entrada para instalaciones de bombeo.